Glimee MV 2mg/500mg/0.3mg Tablet SR
Marketer
Kiama Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimee MV 2mg/500mg/0.3mg Tablet SR
Glimee MV 2mg/500mg/0.3mg SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes mellitus. This medication helps regulate blood glucose in diabetic patients. Administer Glimee MV with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.
Primary Ingredients of Glimee MV 2mg/500mg/0.3mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimee MV 2mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimee MV 2mg/500mg/0.3mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Glimee MV 2mg/500mg/0.3mg Extended-Release Tablet on an empty stomach.
Common Side effects of Glimee MV 2mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimee MV 2mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Glimee MV 2mg/500mg/0.3mg Tablet SR should be swallowed whole and not chewed, crushed, or broken. Administer on an empty stomach.
How Glimee MV 2mg/500mg/0.3mg Tablet SR works:
Glimepiride/Metformin/Pioglitazone extended-release tablets (2mg/500mg/0.3mg) are a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimee MV 2mg/500mg/0.3mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimee MV 2mg/500mg/0.3mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimepiride/Metformin/Pioglitazone combination tablet (2mg/500mg/0.3mg) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glimee MV 2mg/500mg/0.3mg Tablet SR is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is necessary. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimee MV 2mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimee MV 2mg/500mg/0.3mg Tablet SR :
Should you forget to take your Glimee MV 2mg/500mg/0.3mg SR Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimee MV 2mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |
3,018 People bought this recently